Search for drugs:
Typing the drug name to query
OLMESARTAN MEDOXOMIL
DIR Classification
Classification:Less-DIR concern
Severity Score:1
Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF
- ADVERSE REACTIONS
- Post-Marketing Experience:
- The following adverse reactions have been reported in post-marketing experience:
- - Body as a Whole:Asthenia, angioedema
- - Gastrointestinal: Vomiting
- - Metabolic and Nutritional Disorders:Hyperkalemia
- - Musculoskeletal: Rhabdomyolysis
- - Urogenital System: Acute renal failure, increased blood creatinine levels
- - Skin and Appendages: Alopecia, pruritus, urticaria
Postmarketing Surveillance
Contingency Table:
Current Drug
Other Drugs
Rhabdomyolysis
36
42876
Other ADRs
9919
14107360
Odds Ratio = 1.195
Drug Property Information
ATC Code(s):
- C09DA08 - olmesartan medoxomil
- C09DA - Angiotensin II antagonists and diuretics
- C09D - "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS"
- C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
- C - CARDIOVASCULAR SYSTEM
- C09CA08 - olmesartan medoxomil
- C09CA - "Angiotensin II antagonists, plain"
- C09C - "ANGIOTENSIN II ANTAGONISTS, PLAIN"
- C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
- C - CARDIOVASCULAR SYSTEM
- C09DX03 - olmesartan medoxomil
- C09DX -
- C09D - "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS"
- C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
- C - CARDIOVASCULAR SYSTEM
- C09DB02 - olmesartan medoxomil
- C09DB - Angiotensin II antagonists and calcium channel blockers
- C09D - "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS"
- C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
- C - CARDIOVASCULAR SYSTEM
Active Ingredient:olmesartan medoxomil
Active Ingredient UNII:6M97XTV3HD
Drugbank ID:DB00275
PubChem Compound:158781
CAS Number:144689-24-7
Dosage Form(s):tablet, film coated
Route(s) Of Administrator:oral
Daily Dose:
- 20.0 mg/day C09CA08
Chemical Structure: 
SMILE Code:
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O
Reference
COHORT STUDY:
N/AOTHER REFERENCE(S):
N/ADisclaimer:
The content of this database of rhabdomyolysis is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.
The views presented in this website do not necessarily reflect current or future opinion or policy of the US Food and Drug Administration. Any mention of commercial products is for clarification and not intended as endorsement.